B--Evaluation of R406 levels
ID: 75N92025Q00030Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NHLBIBETHESDA, MD, 20892, USA

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL (B504)

Original Source

https://sam.gov/opp/d19be4f733e0443aa4029bf5568babeb/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the evaluation of R406 levels as part of a presolicitation notice. The objective of this procurement is to conduct specialized studies and analyses related to chemical and biological research, which falls under the NAICS code 541714 for Research and Development in Biotechnology (except Nanobiotechnology). This evaluation is crucial for advancing understanding in the relevant scientific fields and may have significant implications for public health. Interested parties can reach out to Tiffany M. Kennedy at tiffany.kennedy@nih.gov for further information, although specific funding amounts and deadlines have not been disclosed in the current listing.

    Point(s) of Contact
    KENNEDY, TIFFANY M
    +1 000 000 0000
    tiffany.kennedy@nih.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    B--Evaluation of R406 levels
    Currently viewing
    Presolicitation
    Similar Opportunities
    Therakos Inc. Cellex® Photopheresis System Procedural Kits
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking procurement for Cellex® Photopheresis System Procedural Kits. This presolicitation aims to acquire in-vitro diagnostic substances that are crucial for therapeutic procedures involving photopheresis, which is significant in treating certain medical conditions. The performance of this contract will take place in Bethesda, Maryland, and interested vendors can reach out to Shasheshe Goolsby at shasheshe.goolsby@nih.gov or by phone at 301-827-4879 for further details. The timeline for this opportunity and additional funding specifics will be outlined in forthcoming announcements.
    R--Fellowship Senior Program Manager Services
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified vendors to provide Fellowship Senior Program Manager Services. The objective of this procurement is to secure professional consulting services that will support the NIH's National Heart, Lung, and Blood Institute (NHLBI) in managing fellowship programs effectively. These services are crucial for ensuring the successful administration and oversight of fellowship initiatives, which play a vital role in advancing research and training in the health sciences. Interested parties should contact Tara C. Knox at knoxt@nih.gov or +1 301 402 0834 for further details, as this opportunity is set aside for small businesses under the SBA guidelines, with the relevant NAICS code being 541690.
    In Vitro Assessments of Antimicrobial Activity
    Buyer not available
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for the In Vitro Assessments of Antimicrobial Activity (IVAAA) program through solicitation RFP 75N93024R00024. This initiative aims to support in vitro testing to evaluate the therapeutic potential of compounds against over 270 infectious agents, facilitating the development of vaccines, therapeutics, and diagnostics for infectious diseases. The program is critical for enhancing public health preparedness and response capabilities, particularly in addressing emerging health threats such as bioterrorism and infectious diseases. Proposals are due by March 10, 2025, with a funding range of $2,500 to $15 million available through January 14, 2033. Interested parties can direct inquiries to Alexander Beraud at alexander.beraud@nih.gov or Brian Madgey at brian.madgey@nih.gov.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Buyer not available
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    Various Roche Cobas® 5800 Rental Reagent Package with Reagents, Controls, Consumables and Maintenance
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to procure a rental reagent package for the Roche Cobas® 5800 diagnostic system, which includes essential reagents, controls, consumables, and maintenance services. This procurement aims to enhance the capabilities of healthcare facilities in conducting reliable and efficient testing for infectious diseases, particularly for HBV, HCV, and HIV, as outlined in the accompanying catalog of medical kits and components. The extensive range of products available is crucial for public health initiatives, ensuring timely and accurate diagnostics. Interested vendors can reach out to Shasheshe Goolsby at shasheshe.goolsby@nih.gov or call 301-827-4879 for further details regarding this presolicitation opportunity.
    R--Notice of Intent to Sole Source
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), has issued a presolicitation notice for a sole source contract aimed at providing operations, maintenance, and modernization support for ClinicalTrials.gov. The objective of this procurement is to enhance IT services that facilitate the accurate collection, storage, and retrieval of clinical trial data, ensuring compliance with statutory requirements and improving data quality. This initiative is crucial for maintaining transparency and usability of clinical trial information, aligning with the strategic goals of the National Library of Medicine (NLM). Interested parties can contact Delfo R. Mizhquiri at sacomizhquirid2@nih.gov or by phone at +1 301 827 4430 for further details. The expected duration of the support is six months, with a hybrid contract type involving both Firm-Fixed-Price and Time-and-Materials arrangements.
    Qiagen, LLC QIA Instrument Maintenance Service
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the maintenance service of Qiagen, LLC QIA instruments. This procurement aims to ensure the operational efficiency and reliability of electronic and precision equipment used in laboratory settings, which is critical for ongoing research and health initiatives. The services will be performed in Bethesda, Maryland, and interested vendors can reach out to Kimala Winfield at kimala.winfield@nih.gov or 301-496-7015, or Malinda Dehner at DehnerM@cc.nih.gov or 301-594-6320 for further details. The opportunity is currently in the presolicitation phase, and specific deadlines will be communicated as the procurement process progresses.
    Development of Radiation/Nuclear Medical Countermeasures (MCMs) And Biodosimetry Devices
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting proposals for the development of Radiation/Nuclear Medical Countermeasures (MCMs) and biodosimetry devices. The primary objectives are to create effective MCMs that mitigate normal tissue injuries from ionizing radiation and to advance biodosimetry tools that enhance triage and treatment strategies during radiation emergencies. This initiative is crucial for national preparedness against potential radiological incidents, as it aims to address the urgent need for medical interventions and diagnostic capabilities in mass casualty scenarios. Proposals are due by March 19, 2025, with an estimated funding of $2 million annually for successful applicants over a typical three-year contract period, totaling a possible award of $6 million. For further inquiries, interested parties may contact Albert Nguyen at nguyenal@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov.
    L--MedStar Health Interventional Cardiology Services
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking sources for MedStar Health Interventional Cardiology Services. This procurement aims to identify qualified vendors capable of providing specialized interventional cardiology services, which are critical for advancing cardiovascular health and treatment options. The services will support the NIH's mission to improve health outcomes through innovative medical practices and research. Interested parties can reach out to Helmut A. Winffel at helmut.winffel@nih.gov or call +1 301 435 0330 for further information regarding this opportunity.
    FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
    Buyer not available
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), is seeking proposals for the FY25 Broad Agency Announcement (BAA) aimed at advancing research and development in regulatory science. This initiative focuses on enhancing the FDA's product regulation processes, with key research areas including alternative methods, advanced manufacturing techniques, and improved post-market surveillance. The opportunity is open to a diverse range of applicants, including small businesses and academic institutions, and emphasizes the importance of addressing public health challenges and engaging underserved populations. Interested parties must submit a concept paper by November 8, 2024, with the final proposal due by March 4, 2025. For further inquiries, contact Ian Weiss at Ian.Weiss@fda.hhs.gov or call 301-796-5728.